Company / Total Assets
Silo Pharma, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$7.4M
FY2025
5-year range
$493.8K / $7.7M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $8M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +71.9%.
Declined from $8M to $7M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +71.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +71.9%, indicating consistent growth.
- In FY2025, total assets increased 0.0% year-over-year.
- Peak total assets was recorded in FY2023.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.4M | +0.0% |
| FY2024 | $7.4M | -4.3% |
| FY2023 | $7.7M | +1468.5% |
| FY2020 | $493.8K | +0.0% |
| FY2019 | $493.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026